Dosing recommendations are based on clinical research and not standard medical guidelines
Never discontinue tirzepatide abruptly without medical guidance, as this may affect glycemic control and metabolic management
Lastly, while no significant difference was observed in the overall symptom score between groups, specific hyperthyroid symptoms were significantly lower in the intervention group, including irritability, tremor, mood lability, heat intolerance, and exertional dyspnea
Neuroreport (2008) 19(13):13358.10.1097/WNR.0b013e32830b8afa 82 LinYDesboisAJiangSHouST
Neuroinflammation Pathways: A General Review
This rebound phenomenon is not unique to semaglutide but is rather a common occurrence when individuals stop effective weight loss treatmentswhether pharmacologic or behavioral